Pfizer has low forward P/E ratios for the next five years. The FY2027 forward P/E ratio is low at 8.61. On the other hand, we see that the ratio will not shrink significantly between FY2024 and FY2027 ...
The global auto-injectors market is set to reach a significant valuation of US$ 30,578.2 million in 2023, marking a strong ...
Thailand Pharmaceutical Industry, according to Fitch Solutions, the pharmaceutical market in Southeast Asia has a market size ...
Examples: Look at companies like Pfizer, Johnson & Johnson, Merck, and Eli Lilly. Broad exposure can be gained through ETFs like the Health Care Select Sector SPDR Fund (XLV). Rationale: Lower taxes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback